Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate vs. Consecutive Day Oral Iron in Pregnancy
NCT06492512Phase 4Recruiting
- Sponsor
- Southern Illinois University
- Start
- May 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Southern Illinois University. Primary endpoint: Reversal of iron deficient anemia at 8 weeks. Started May 2025; status: recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06492512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06492512.